Track the Beta Drugs Limited share price and the full management transaction log of the company, a listed issuer based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Beta Drugs Limited has recorded 9 public disclosures. Market capitalisation: €22.5bn. The latest transaction was reported on 13 November 2025 (Sale). Among the most active insiders: Rahul Batra. Every trade is free.
9
Insider Decl.
n/a
Thresholds
€56,689
8 ops.
Buy Volume
€3m
1 ops.
Sell Volume
10Σ signal
Buys €56,689€3m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,035 of 28,855 companies
50.9
score / 100
Value
31
Quality
71
FCF yld-0.7%
Earn yld1.8%
EV/EBITDA27.6x
ROE19%
Gross mgn56%
Net mgn11%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.